Current therapy for CLL and the new monoclonal antibody ofatumumab
Lymphoid Highlights from BSH 2017
Is FISH becoming obsolete in multiple myeloma?
CheckMate study and the role of nivolumab in Hodgkin lymphoma
Conflicting results of the EMN02 and staMINA trials